Can Clot-Removing devices improve stroke recovery?

NCT ID NCT07760649

Not yet recruiting Disease control Sponsor: Neuravi Limited Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study tracks the safety and effectiveness of J&J MedTech devices used to remove blood clots in people with acute ischemic stroke. It will follow about 5,000 adults who receive these devices as part of their routine care, measuring how well blood flow is restored and how patients recover over 90 days. The goal is to see how these approved devices perform in real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: J&J MedTech neurovascular thrombectomy devices (commercially approved)
What this could lead to: If successful, this study could confirm that these devices are safe and effective in everyday stroke treatment, potentially improving outcomes for many patients.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient differences, and device risks like bleeding or vessel damage remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE

Contacts and locations

Locations

Stadtisches Klinikum Solingen gemeinnutzige GmbH

Solingen, 42653, Germany
Universitaetsklinikum Hamburg Eppendorf

Hamburg, 20251, Germany
University Hospital Zurich

Zurich, 8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.